C.ANIRUDH JAGANNADH, M.SRAVANI, and DR M.D DHANARAJU. 2013. “ALEGLITAZAR – AN UPCOMING DUAL PPAR ALPHA GAMMA AGONIST REDUCING THE MACRO VASCULAR RISKS ASSOCIATED WITH TYPE 2 DIABETES MELLITUS”. International Journal of Pharma and Bio Sciences 4 (2):750-54. https://ijpbs.net/index.php/journal/article/view/2225.